Zimmer Biomet Holdings (ZBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,200 | 1,131,500 | -379,300 | 1,813,400 | 304,600 |
| Depreciation Amortization | 1,401,400 | 1,076,200 | 2,020,200 | 1,394,200 | 1,070,400 |
| Income taxes - deferred | 39,400 | -538,700 | 13,400 | -1,776,000 | -153,200 |
| Accounts receivable | -66,200 | -93,800 | 213,600 | 161,700 | -141,600 |
| Other Working Capital | -429,800 | -167,500 | 27,600 | 64,200 | -23,500 |
| Other Operating Activity | 140,000 | 178,100 | -148,100 | -75,200 | 575,500 |
| Operating Cash Flow | $1,075,600 | $1,585,800 | $1,747,400 | $1,582,300 | $1,632,200 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -1,500 |
| PPE Investments | -370,900 | -523,000 | -439,000 | -493,000 | -530,200 |
| Net Acquisitions | -227,100 | -37,100 | -15,300 | -4,000 | -1,443,000 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 286,200 |
| Purchase Sale Intangibles | N/A | -197,600 | N/A | N/A | N/A |
| Other Investing Activity | 33,700 | -169,200 | 37,700 | -13,800 | -3,000 |
| Investing Cash Flow | $-564,300 | $-729,300 | $-416,600 | $-510,800 | $-1,691,500 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,497,100 | 749,200 | 1,824,500 | 592,700 | 1,823,500 |
| Debt Repayment | -1,750,000 | -1,465,300 | -2,978,900 | -1,840,900 | -2,083,100 |
| Common Stock Issued | 129,800 | 158,200 | 107,900 | 145,500 | 136,600 |
| Common Stock Repurchased | 0 | N/A | N/A | N/A | -415,500 |
| Dividend Paid | -198,500 | -196,700 | -195,200 | -193,600 | -188,400 |
| Other Financing Activity | -98,600 | -25,300 | -60,500 | 85,800 | -16,300 |
| Financing Cash Flow | $-420,200 | $-779,900 | $-1,302,200 | $-1,210,500 | $-743,200 |
| Exchange Rate Effect | 15,300 | -1,500 | -10,200 | 29,300 | -22,700 |
| Beginning Cash Position | 617,900 | 542,800 | 524,400 | 634,100 | 1,459,300 |
| End Cash Position | 802,100 | 617,900 | 542,800 | 524,400 | 634,100 |
| Net Cash Flow | $184,200 | $75,100 | $18,400 | $-109,700 | $-825,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,075,600 | 1,585,800 | 1,747,400 | 1,582,300 | 1,632,200 |
| Capital Expenditure | -370,900 | -523,000 | -439,000 | -493,000 | -530,200 |
| Free Cash Flow | 704,700 | 1,062,800 | 1,308,400 | 1,089,300 | 1,102,000 |